Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Cox A et al. |
A common coding variant in CASP8 is associated with breast cancer risk.
|
|
2 |
Easton DF et al. |
Genome-wide association study identifies novel breast cancer susceptibility loci.
|
|
3 |
Erkko H et al. |
A recurrent mutation in PALB2 in Finnish cancer families.
|
|
4 |
Hartikainen JM et al. |
Screening for BRC A1 and BRC A2 mutations in Eastern Finnish breast/ovarian cancer families .
|
|
5 |
Hartikainen JM et al. |
Screening for BRCA1 and BRCA2 mutations in Eastern Finnish breast/ovarian cancer families.
|
|
6 |
Hartikainen JM et al. |
A BRCA2 mutation, 4088insA, in a Finnish breast and ovarian cancer family associated with favourable clinical course.
|
|
7 |
Jantunen E, Kataja V. |
Mukosiitti - syövän hoidon merkittävä pulma.
|
|
8 |
Karihtala P et al. |
Hyaluronan in breast cancer: correlations with nitric oxide synthases and tyrosine nitrosylation.
|
|
9 |
Kataja VV. |
Recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis,treatment and follow-up.
|
|
10 |
Kellokumpu-Lehtinen P et al. |
Anemia kiinteiden syöpäkasvainten yhteydssä.
|
|
11 |
Kosunen A et al. |
CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
|
|
12 |
Leinonen T et al. |
Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer.
|
|
13 |
Pukkila M et al. |
High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
|
|
14 |
Pulkkanen K et al. |
Effective palliation without normal tissue toxicity using low-dosw ultrafractionated re-irradiation for tumor recurrence after radical or adjuvant radiotherapy.
|
|
15 |
Sillanpää P et al. |
CYP1A1 and CYP1B1 genetic polymorphisms, smoking and breast cancer risk in a Finnish caucasian population.
|